Oncology Institute Inc (NASDAQ:TOI) price on Wednesday, April 30, fall -0.80% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.48.
A look at the stock’s price movement, the close in the last trading session was $2.50, moving within a range at $2.17 and $2.52. The beta value (5-Year monthly) was 0.238. Turning to its 52-week performance, $3.50 and $0.13 were the 52-week high and 52-week low respectively. Overall, TOI moved 117.54% over the past month.
Oncology Institute Inc’s market cap currently stands at around $187.86 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Aug-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TOI is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend TOI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TOI’s current price about 16.76% and 79.82% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.60, while 7-day volatility ratio is 21.96% and 21.82% in the 30-day chart. Further, Oncology Institute Inc (TOI) has a beta value of 0.05, and an average true range (ATR) of 0.38. Analysts have given the company’s stock an average 52-week price target of $8, forecast between a low of $6 and high of $10. Looking at the price targets, the low is -141.94% off current price level while to achieve the yearly target high, price needs to move -303.23%. Nonetheless, investors will most likely welcome a -222.58% jump to $8 which is the analysts’ median price.
If we refocus on Oncology Institute Inc (NASDAQ:TOI), historical trading data shows that trading volumes averaged 1.79 over the past 10 days and 935.56K over the past 3 months. The company’s latest data on shares outstanding shows there are 75.74 million shares.
The 57.08% of Oncology Institute Inc’s shares are in the hands of company insiders while institutional holders own 14.99% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.35 million on 2025-04-15, giving us a short ratio of 1.37. The data shows that as of 2025-04-15 short interest in Oncology Institute Inc (TOI) stood at 190.0 of shares outstanding, with shares short rising to 1.1 million registered in 2025-03-14. Current price change has pushed the stock 702.59% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TOI stock continues to rise going into the next quarter.
